Top Markets
Coin of the day
GlobeStar Therapeutics Corporation GlobeStar Therapeutics Corporation

GlobeStar Therapeutics Corporation

GSTC
Rank in Stocks #40541
GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm... GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing proprietary drug formulations. These innovative treatments specifically target multiple sclerosis (MS) and various other neurodegenerative disorders. Established in 2016, the company was formerly known as AngioSoma, Inc., rebranding to GlobeStar Therapeutics Corporation in July 2021. Its operations are headquartered in Richland, Washington.
Share Price
$0.0001
Last synced: 2026-08-12
Market Cap
$124.11K
Change (1 day)
0.00%
Change (1 year)
9,900.00%
Country
US
Trade GlobeStar Therapeutics Corporation (GSTC)

Category

Operating Margin for GlobeStar Therapeutics Corporation (GSTC)
Operating Margin as of 2026 TTM: 0.00%
According to GlobeStar Therapeutics Corporation latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for GlobeStar Therapeutics Corporation from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.97% -
US
28.81% -
NL
0.00% -
CH
0.00% -
KR
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.